EUVIMEDEUVIMED entdecken
Crossref

Targeting Cyclophilin A in the Cardiac Microenvironment Preserves Heart Function and Structure in Failing Hearts

Manuel Sigle iD, Anne-Katrin Rohlfing iD, Melanie Cruz Santos, Timo Kopp iD, Konstantin Krutzke iD, Vincent Gidlund, Ferdinand Kollotzek iD, Julia Marzi iD, Saskia von Ungern-Sternberg, Antti Poso iD, Mathias Heikenwälder, Katja Schenke-Layland iD und 11 weitere

Circulation Research · 13.09.2024 · 135 (7) · 758-773

DOI: 10.1161/circresaha.124.324812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, erschienen am 13.09.2024. Verfasst von Manuel Sigle und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Angiology (M.S., A.-K.R., F.K., S.U.-S., P.S., O.B., K.A.L.M., M.P.G., D.H.), Eberhard Karls University Tübingen, German…. Hauptthemen laut MEDLINE: Cyclophilin A, Heart Failure. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiac hypertrophy is characterized by remodeling of the myocardium, which involves alterations in the ECM (extracellular matrix) and cardiomyocyte structure. These alterations critically contribute to impaired contractility and relaxation, ultimately leading to heart failure. Emerging evidence implicates that extracellular signaling molecules are critically involved in the pathogenesis of cardiac hypertrophy and remodeling. The immunophilin CyPA (cyclophilin A) has been identified as a potential culprit. In this study, we aimed to unravel the interplay between eCyPA (extracellular CyPA) and myocardial dysfunction and evaluate the therapeutic potential of inhibiting its extracellular accumulation to improve heart function. METHODS: Employing a multidisciplinary approach encompassing in silico, in vitro, in vivo, and ex vivo experiments we studied a mouse model of cardiac hypertrophy and human heart specimen to decipher the interaction of CyPA and the cardiac microenvironment in highly relevant pre-/clinical settings. Myocardial expression of CyPA (immunohistology) and the inflammatory transcriptome (NanoString) was analyzed in human cardiac tissue derived from patients with nonischemic, noninflammatory congestive heart failure (n=187). These analyses were paralleled by a mouse model of Ang (angiotensin) II–induced heart failure, which was assessed by functional (echocardiography), structural (immunohistology, atomic force microscopy), and biomolecular (Raman spectroscopy) analyses. The effect of inhibiting eCyPA in the cardiac microenvironment was evaluated using a newly developed neutralizing anti-eCyPA monoclonal antibody. RESULTS: We observed a significant accumulation of eCyPA in both human and murine-failing hearts. Importantly, higher eCyPA expression was associated with poor clinical outcomes in patients ( P =0.043) and contractile dysfunction in mice (Pearson correlation coefficient, −0.73). Further, myocardial expression of eCyPA was critically associated with an increase in myocardial hypertrophy, inflammation, fibrosis, stiffness, and cardiac dysfunction in vivo. Antibody-based inhibition of eCyPA prevented (Ang II)-induced myocardial remodeling and dysfunction in mice. CONCLUSIONS: Our study provides strong evidence of the pathogenic role of eCyPA in remodeling, myocardial stiffening, and dysfunction in heart failure. The findings suggest that antibody-based inhibition of eCyPA may offer a novel therapeutic strategy for nonischemic heart failure. Further research is needed to evaluate the translational potential of these interventions in human patients with cardiac hypertrophy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclophilin AHeart FailureAnimalsFemaleHumansMaleMiceCellular MicroenvironmentDisease Models, AnimalMice, Inbred C57BLMyocardiumMyocytes, CardiacVentricular Remodeling

Stichwörter der Autor:innen

cyclophilin Ahypertrophyinflammationmyocardium

Substanzen

Cyclophilin A

Autor:innen und Institutionen

  • Department of Cardiology and Angiology (M.S., A.-K.R., F.K., S.U.-S., P.S., O.B., K.A.L.M., M.P.G., D.H.), Eberhard Karls University Tübingen, Germany.
  • Institute of Pharmacy, Pharmacology, Toxicology and Clinical Pharmacy (M.C.S., R.L.), University of Tübingen, Germany.
  • Interfaculty Institute of Biochemistry (IFIB) (T.K., R.F., S.F.), University of Tübingen, Germany.
  • Institute for Applied Physics (K.K., V.G., T.E.S.), University of Tübingen, Germany.
  • DFG Heisenberg Group Cardiovascular Thrombo-Inflammation and Translational Thrombocardiology (F.K., O.B.), University of Tübingen, Germany.
  • Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine (J. Marzi, K.S.-L.), Eberhard Karls University Tübingen, Germany.

ORCID-Profile: Manuel Sigle, Anne-Katrin Rohlfing, Timo Kopp, Konstantin Krutzke, Ferdinand Kollotzek, Julia Marzi, Antti Poso, Katja Schenke-Layland, Nikolaus Marx, Robert Feil, Susanne Feil, Robert Lukowski, Oliver Borst, Tilman E Schäffer, Karin Anne Lydia Müller

Zitieren

APA

Sigle, M., Rohlfing, A. K., Cruz Santos, M., Kopp, T., Krutzke, K., Gidlund, V., Kollotzek, F., Marzi, J., von Ungern-Sternberg, S., Poso, A., Heikenwälder, M., Schenke-Layland, K., Seizer, P., Möllmann, J., Marx, N., Feil, R., Feil, S., Lukowski, R., Borst, O., …, & Heinzmann, D. (2024). Targeting Cyclophilin A in the Cardiac Microenvironment Preserves Heart Function and Structure in Failing Hearts. Circulation Research, 135(7), 758-773. https://doi.org/10.1161/circresaha.124.324812

Vancouver

Sigle M, Rohlfing AK, Cruz Santos M, Kopp T, Krutzke K, Gidlund V, et al. Targeting Cyclophilin A in the Cardiac Microenvironment Preserves Heart Function and Structure in Failing Hearts. Circulation Research. 2024;135(7):758-773. doi:10.1161/circresaha.124.324812

BibTeX
@article{Sigle2024,
  author = {Sigle, Manuel and Rohlfing, Anne-Katrin and Cruz Santos, Melanie and Kopp, Timo and Krutzke, Konstantin and Gidlund, Vincent and Kollotzek, Ferdinand and Marzi, Julia and von Ungern-Sternberg, Saskia and Poso, Antti and Heikenwälder, Mathias and Schenke-Layland, Katja and Seizer, Peter and Möllmann, Julia and Marx, Nikolaus and Feil, Robert and Feil, Susanne and Lukowski, Robert and Borst, Oliver and Schäffer, Tilman E and Müller, Karin Anne Lydia and Gawaz, Meinrad P and Heinzmann, David},
  title = {Targeting Cyclophilin A in the Cardiac Microenvironment Preserves Heart Function and Structure in Failing Hearts},
  journal = {Circulation Research},
  year = {2024},
  volume = {135},
  number = {7},
  pages = {758--773},
  doi = {10.1161/circresaha.124.324812}
}
Kostenlos starten →